145508-90-3

Usage

Uses

Used in Pharmaceutical Industry:
5-Methoxy-3-methylbenzodisoxazole is used as a potential pharmaceutical candidate for the development of drugs due to its demonstrated biological activities. As a benzodisoxazole derivative, it has shown antimicrobial, anticancer, and anti-inflammatory properties, making it a promising compound for further research and development in the pharmaceutical field.
However, it is important to note that the specific applications and reasons for using 5-Methoxy-3-methylbenzodisoxazole in the pharmaceutical industry are not explicitly mentioned in the provided materials. Further research is needed to fully understand and utilize the potential applications of 5-METHOXY-3-METHYLBENZODISOXAZOLE.

Upstream product

• 1215858-72-2 (Z)-1-(2-bromophenyl)ethanone oxime 
• 23997-97-9 (E)-2-hydroxy-5-methoxyacetophenone oxime 
• 705-15-7 1-(2-hydroxy-5-methoxyphenyl)ethan-1-one 
• 490-78-8 2,5-Dihydroxyacetophenone 
• 24558-42-7 1-(2,5-dihydroxyphenyl)ethan-1-one oxime 
• 214760-36-8 5-hydroxy-3-methylbenzo[d]isoxazole 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 1394900-10-7 benzyl 1-(2-hydroxy-5-methoxyphenyl)-1-ethylcarbamate 

Relevant academic research and scientific papers

Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: Excellent substrates for NAD(P)H:quinone oxidoreductase 1

A series of heterocyclic quinones based on benzofuran, benzothiophene, indazole and benzisoxazole has been synthesized, and evaluated for their ability to function as substrates for recombinant human NAD(P)H:quinone oxidoreductase (NQO1), a two-electron reductase upregulated in tumor cells. Overall, the quinones are excellent substrates for NQO1, approaching the reduction rates observed for menadione.

Amino sulfonyl compound, preparation method and uses thereof

The present invention relates to a new amino sulfonyl compound represented by a general formula I, or a tautomer, an enantiomer, a racemate or a pharmaceutically acceptable salt thereof, a preparation method, a pharmaceutical composition, and uses thereof, wherein the compound can be used for treatment of epilepsy, convulsion, obesity, and the like. The general formula I is defined in the specification.

Copper-catalyzed cyclization of Z-oximes into 3-methyl-1,2-benzisoxazoles

A practical and effective room temperature copper-catalyzed cyclization of Z-oximes is developed. 3-Methyl-1,2-benzisoxazoles are obtained in 58-79% yields. Also, the Z-selective synthesis of o-bromo acetophenone oximes is presented for the first time.